Evidence map›Paper›PMID 29131146›Full record

ArticleNature chemical biology2018

Synthetic microbial consortia enable rapid assembly of pure translation machinery.

Fernando Villarreal, Luis E Contreras-Llano, Michael Chavez, Yunfeng Ding, Jinzhen Fan, Tingrui Pan, Cheemeng Tan

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Cell-Free Display Techniques for Protein Evolution.Advances in biochemical engineering/biotechnology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. High-Throughput Experimentation Using Cell-Free Protein Synthesis Systems.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  13. Review
  14. Review
  15. Review
  16. Decentralizing Cell-Free RNA Sensing With the Use of Low-Cost Cell Extracts.Frontiers in bioengineering and biotechnology · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fernando VillarrealDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.
Luis E Contreras-LlanoDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.
Michael ChavezDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.
Yunfeng DingDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.
Jinzhen FanDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.
Tingrui PanDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.
Cheemeng TanDepartment of Biomedical Engineering, University of California Davis, Davis, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Assembly of recombinant multiprotein systems requires multiple culturing and purification steps that scale linearly with the number of constituent proteins. This problem is particularly pronounced in the preparation of the 34 proteins involved in transcription and translation systems, which are fundamental biochemistry tools for reconstitution of cellular pathways ex vivo. Here, we engineer synthetic microbial consortia consisting of between 15 and 34 Escherichia coli strains to assemble the 34 proteins in a single culturing, lysis, and purification procedure. The expression of these proteins is controlled by synthetic genetic modules to produce the proteins at the correct ratios. We show that the pure multiprotein system is functional and reproducible, and has low protein contaminants. We also demonstrate its application in the screening of synthetic promoters and protease inhibitors. Our work establishes a novel strategy for producing pure translation machinery, which may be extended to the production of other multiprotein systems.

Indexed as

Escherichia coliEscherichia coli ProteinsMicrobial ConsortiaProtein BiosynthesisProtein EngineeringRecombinant ProteinsSynthetic BiologyEscherichia coli ProteinsRecombinant Proteins

Identifiers

PMID29131146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.